Covid-19 Alert: if you have cold or flu-like symptoms (fever, cough, difficulty breathing, body aches, or chills, headache, sore throat, or loss of taste or smell), you must call us at 515.282.2921 before coming into Mission Cancer + Blood, even if you have an appointment. Tell us about your symptoms before coming in – Thank you!

NON-SMALL CELL E4512

Study #E4512

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein (must be enrolled on screening trial A151216).

Back To Clinical Trials